After 40 weeks, the mice treated with rAAV8 apoA1 Milano demonstrated a substantial reduction of atherosclerosis, while there was no such positive effect in mice treated with empty rAAV8, and they were sacrificed before the experiment had started. The gene discussed is APOA1; the disease is atherosclerosis.